Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				6 Months Ended
	Jun. 30, 2012		Jun. 30, 2011		Jun. 30, 2012		Jun. 30, 2011
Revenues:
Product sales	$ 1,147.7		$ 993.3		$ 2,254.6		$ 1,882.6
Royalties	56.3		63.4		112.6		137.0
Other revenues	3.8		6.2		12.4		15.5
Total revenues	1,207.8		1,062.9		2,379.6		2,035.1
Costs and expenses:
Cost of product sales	152.5	[1]	143.7	[1]	310.9	[1]	268.2	[1]
Research and development	238.6	[1]	176.9	[1]	458.9	[1]	354.8	[1]
Selling, general and administrative ("SG&A")	511.0	[1]	440.3	[1]	1,011.0	[1]	843.2	[1]
(Gain)/loss on sale of product rights	(3.6)		2.2		(10.8)		3.5
Reorganization costs	0		7.5		0		13.0
Integration and acquisition costs	7.1		9.0		12.4		2.6
Total operating expenses	905.6		779.6		1,782.4		1,485.3
Operating income	302.2		283.3		597.2		549.8
Interest income	0.6		0.6		1.4		1.2
Interest expense	(9.6)		(9.9)		(19.8)		(19.1)
Other (expense)/income, net	(1.8)		0		0.1		0.3
Total other expense, net	(10.8)		(9.3)		(18.3)		(17.6)
Income before income taxes and equity in (losses)/earnings of equity method investees	291.4		274.0		578.9		532.2
Income taxes	(53.0)		(69.7)		(103.0)		(117.8)
Equity in (losses)/earnings of equity method investees, net of taxes	(0.6)		1.2		0.3		2.4
Net income	237.8		205.5		476.2		416.8
Numerator for basic earnings per share	237.8		205.5		476.2		416.8
Earning per ordinary share - basic
Earnings per ordinary share - basic	$ 0.427		$ 0.372		$ 0.858		$ 0.757
Earnings per ordinary share - diluted
Earnings per ordinary share - diluted	$ 0.413		$ 0.359		$ 0.828		$ 0.729
Weighted average number of shares:
Basic	557.0		552.3		555.2		551.1
Diluted	594.9		595.1		594.8		594.8
Amounts attributable to Shire plc
Numerator for basic earnings per share	$ 237.8		$ 205.5		$ 476.2		$ 416.8

[1] Cost of product sales includes amortization of intangible assets relating to favorable manufacturing contracts of $0.5 million for the three months to June 30, 2012 (2011: $0.4 million) and $0.7 million for the six months to June 30, 2012 (2011: $0.9 million). Research and development costs includes intangible asset impairment charges of $27.0 million for the three and six months to June 30, 2012 (2011: $nil). SG&A costs includes amortization of intangible assets relating to intellectual property rights acquired of $51.0 million for the three months to June 30, 2012 (2011: $36.7 million) and $96.6 million for the six months to June 30, 2012 (2011: $72.7 million).